130 results
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
15 May 24
Condensed consolidated interim financial statements
6:02am
the three months ended March 31, 2023, the Company granted 400,000 PSUs to independent directors who are no longer with the Company.
RSUs
On February 23 … of shareholders on May 14, 2021, pending the outcome of an investigation of various concerns by a Special Committee comprised of independent directors using
6-K
EX-99.2
HUGE
FSD Pharma Inc - Ordinary Shares
15 May 24
Condensed consolidated interim financial statements
6:02am
(2023 – $49,932).
During the three months ended March 31, 2024, the Company granted Nil (2023 – 400,000) PSUs to independent members of the Board
6-K
EX-10.1
hkbp853unyzud0aw0w3
20 Feb 24
FSD Pharma Announces US ATM Offering
6:01am
424B5
dk5h4vxt
16 Feb 24
Prospectus supplement for primary offering
6:36pm
F-3
hzpbjksx15 ntjia
22 Dec 23
Shelf registration (foreign)
6:49pm
F-3
EX-23.1
fw3km9w
22 Dec 23
Shelf registration (foreign)
6:49pm
F-3
EX-5.1
9fttir48tl okn093
22 Dec 23
Shelf registration (foreign)
6:49pm
6-K
EX-99.2
zx5lr8cu f38
15 Nov 23
Condensed consolidated interim financial statements
12:00am
6-K
EX-99.1
guswq1u7k7vum
15 Nov 23
Condensed consolidated interim financial statements
12:00am
6-K
EX-99.1
1nslj9lrgkaici76ie
20 Jul 23
Condensed consolidated interim financial statements
5:05pm
6-K
EX-99.2
pvyk84gmzhb9o612muoe
20 Jul 23
Condensed consolidated interim financial statements
5:05pm
6-K
EX-99.2
9icph
12 May 23
Condensed consolidated interim financial statements
6:55pm
6-K
EX-99.1
o6v00z5
12 May 23
Condensed consolidated interim financial statements
6:55pm